vimarsana.com

Treadwell Announces Ocifisertib, a First-in-Class PLK4 Inhibitor, has Received Orphan Designation from U.S. FDA for the Treatment of Acute Myeloid Leukemia

Treadwell Announces Ocifisertib, a First-in-Class PLK4 Inhibitor, has Received Orphan Designation from U.S. FDA for the Treatment of Acute Myeloid Leukemia

lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United Kingdom ,Brenda Marczi ,Roger Sidhu ,Drug Administration ,Regulatory Affairs At Tracon Pharmaceuticals Inc ,Product Service ,Regulatory Affairs At Treadwell ,Rutgers University ,Head Of Regulatory Affairs ,University Of Maryland ,University Of Pennsylvania ,Announces Ocifisertib ,Received Orphan Designation ,Acute Myeloid ,Drug Act ,Senior Vice President ,Regulatory Affairs ,Tracon Pharmaceuticals ,Pharmaceutical Sciences ,

vimarsana.com © 2020. All Rights Reserved.